Abstract
This brief report compares and contrasts the American Society of Clinical Oncology/College of American Pathologists guidelines for breast cancer predictive factor testing including the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor, type 2, erbB2 Guideline published in 2007 and the recently published Guideline for Estrogen Receptor and Progesterone Receptor Testing by Immunohistochemistry, published in 2011.
MeSH terms
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / immunology
-
Breast Neoplasms / pathology*
-
Early Detection of Cancer
-
Estrogen Receptor beta / immunology
-
Estrogen Receptor beta / metabolism
-
Female
-
Humans
-
Immunohistochemistry / methods
-
Immunohistochemistry / standards*
-
Practice Guidelines as Topic
-
Prognosis
-
Receptor, ErbB-2 / immunology
-
Receptor, ErbB-2 / metabolism
-
Receptors, Progesterone / immunology
-
Receptors, Progesterone / metabolism
-
Reference Standards
-
United States
Substances
-
Estrogen Receptor beta
-
Receptors, Progesterone
-
ERBB2 protein, human
-
Receptor, ErbB-2